Welcome to our dedicated page for BHG news (Ticker: BHG), a resource for investors and traders seeking the latest updates and insights on BHG stock.
Bright Health Group Inc (ticker: BHG) operated as a health insurance company that made headlines throughout its lifecycle as it pursued an ambitious vision of transforming American healthcare. News coverage of Bright Health Group focused on the company's rapid expansion into new markets, its innovative Care Partner model, significant fundraising milestones, and eventual strategic transformation.
During its growth phase, Bright Health Group frequently announced new market entries and partnerships with prominent health systems across the United States. The company generated news through its expansion into additional states, launches of Medicare Advantage plans in new regions, and acquisitions of existing health insurance businesses. Media coverage highlighted the company's technology-focused approach to health insurance and its efforts to differentiate itself from traditional insurers through consumer-centric products and streamlined digital experiences.
Financial news dominated coverage during the company's initial public offering, when Bright Health Group went public on the New York Stock Exchange under the ticker symbol BHG. The IPO attracted significant attention from business and financial media, with coverage analyzing the company's valuation, growth trajectory, and competitive positioning within the health insurance marketplace. Subsequent financial reporting focused on quarterly earnings results, membership growth figures, and the company's ongoing efforts to achieve profitability while expanding operations.
As Bright Health Group faced challenges in the health insurance market, news coverage shifted to the company's strategic response. Announcements regarding the cessation of individual insurance offerings, plans to divest Medicare Advantage operations, and the decision to sell portions of the business to other insurers generated substantial media coverage. The company's strategic transformation from health insurer to care delivery organization, along with the rebranding to NeueHealth and ticker change from BHG to NEUE, marked a significant chapter in the company's news history. Coverage of Bright Health Group provides insights into the challenges and opportunities facing companies attempting to innovate within the complex and heavily regulated health insurance industry.
NeueHealth (NYSE: NEUE) has completed its previously announced take-private merger with New Enterprise Associates (NEA) in a transaction valued at approximately $1.465 billion. Common stockholders will receive $7.33 per share in cash, while certain stockholders including NEA and 12 existing investors have opted to roll over their shares into the private entity.
The company's executive leadership team, including President and CEO Mike Mikan, will maintain their positions and have agreed to roll over 100% of their equity interests. Following the transaction completion, NeueHealth's common stock ceased trading on the NYSE on October 2, 2025, and the company will terminate its SEC reporting obligations.
NeueHealth (NYSE:NEUE) reported strong Q2 2025 financial results, marking its sixth consecutive quarter of Adjusted EBITDA profitability. The company served approximately 694,000 consumers, representing a 45% increase from Q2 2024.
Key financial metrics for Q2 2025 include revenue of $209.1 million, net income from continuing operations of $6.8 million, and Adjusted EBITDA of $19.0 million. The company's value-based consumers increased to 546,000, up from 364,000 in the previous year, while enablement services lives grew to 148,000 from 113,000.
The company continues to advance its end-to-end, value-based care enablement platform across ACA Marketplace, Medicare, and Medicaid product categories.
NeueHealth (NYSE:NEUE), a value-driven healthcare company, has scheduled its second quarter 2025 earnings conference call for Thursday, August 7, 2025. The company will release its financial results before market open, followed by a conference call at 8:00 AM Eastern Time.
Participants must pre-register online to receive dial-in details. The earnings call will be accessible via webcast through NeueHealth's Investor Relations website at investors.neuehealth.com. A recording of the call and presentation materials will be available on the website after the event.
NeueHealth (NYSE: NEUE) reported its Q1 2025 financial results, marking its fifth consecutive quarter of positive Adjusted EBITDA. The company served approximately 709,000 consumers, representing a 51% increase from Q1 2024. Key metrics show 571,000 value-based consumers (up from 360,000) and 138,000 enablement services lives (up from 109,000).
However, revenue decreased to $215.8 million from $245.1 million in Q1 2024. The company reported a net loss of $10.8 million, compared to a $4.2 million loss in the previous year. Adjusted EBITDA improved significantly to $13.5 million, up from $3.7 million in Q1 2024.
NeueHealth (NYSE: NEUE) has scheduled its first quarter 2025 earnings conference call for May 8, 2025. The company will release its financial results before markets open, followed by a conference call at 8:00 AM Eastern Time.
Participants must pre-register online to receive dial-in details, including their personal access code. The company recommends joining the call 15 minutes early. The earnings presentation will be accessible through NeueHealth's Investor Relations website, with a recording available after the event.
NeueHealth (NYSE: NEUE) has reported its Q4 and full year 2024 financial results, marking its strongest financial performance to date. The company achieved positive Adjusted EBITDA for four consecutive quarters in 2024, demonstrating the success of its value-driven, consumer-centric care model.
Starting 2025, NeueHealth has expanded its consumer base to 717,000, representing a significant 48% increase compared to 2024. The company positions itself for continued strategic growth in 2025, focusing on market expansion and strengthening relationships with payors and providers to deliver a more coordinated care experience.
NeueHealth (NYSE: NEUE) has scheduled its fourth quarter and full year 2024 earnings release for March 20, 2025. The company will announce financial results before market open, followed by a conference call at 8:00 AM Eastern Time.
Participants must pre-register for the telephone conference and will receive access details via email. A webcast option will be available through the company's Investor Relations website at investors.neuehealth.com. The company recommends participants dial in 15 minutes before the call starts. Both the earnings call recording and presentation materials will be accessible on NeueHealth's Investor Relations page after the event.
NeueHealth (NYSE: NEUE) has announced a definitive merger agreement to be acquired by New Enterprise Associates (NEA) at an enterprise value of approximately $1.3 billion. Shareholders will receive $7.33 per share in cash, representing a 70% premium over the December 23, 2024 closing price. Following the transaction, NeueHealth will become privately held, with the current executive team maintaining their roles and rolling over 100% of their equity interests. NEA and 12 existing investors will continue their investments by exchanging shares for new equity interests. The merger includes a 30-day 'go-shop' period expiring January 23, 2025, and is subject to stockholder approval and regulatory clearances.
NeueHealth (NYSE: NEUE) reported Q3 2024 financial results, marking its third consecutive quarter of positive Adjusted EBITDA. Revenue reached $232.9 million in Q3 2024, down from $269.4 million in Q3 2023. The company reported a net loss of $40.4 million, significantly improved from a $547.1 million loss in Q3 2023. Value-Based Consumers served increased to 390,000 from 355,000 year-over-year. The company reaffirmed its 2024 guidance, expecting revenue of approximately $950 million and Adjusted EBITDA between $15-25 million.
NeueHealth (NYSE: NEUE) has announced the acquisition of the remaining 25% equity interest in Centrum Health, making it a wholly owned subsidiary. The transaction aims to simplify NeueHealth's corporate structure and streamline operations to support its value-driven, consumer-centric care model. According to CEO Mike Mikan, this move positions NeueHealth to create a more coordinated healthcare experience. Additional details about the transaction will be disclosed in an upcoming Form 8-K filing with the SEC.
